Pulsed-dose rate brachytherapy for pediatric bladder prostate rhabdomyosarcoma: Compliance and early clinical results
Radiotherapy & Oncology Aug 11, 2017
Chargari C, et al. – This study was formulated to delineate pulsed dose rate (PDR) brachytherapy for pediatric bladder prostate rhabdomyosarcoma. Demonstrating an association with acceptable acute toxicity rates, PDR brachytherapy was feasible in very young patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
